Hydrogel-encapsulated heterogenous mesoporous resin catalyst for in situ anti-cancer agent production under biological conditions

HIGHLIGHTS

• who: Mahboubeh Nabavinia and collaborators from the Department of Chemical Engineering, Rowan University, Glassboro, NJ, USA have published the paper: Hydrogel-Encapsulated Heterogenous Mesoporous Resin Catalyst for In Situ Anti-Cancer Agent Production under Biological Conditions, in the Journal: Biomolecules 2022, 12, 1796. of 25/Nov/2022
• what: The authors examine a heterogenous Pd-anchored Resorcinol-formaldehydehyperbranched PEI nanostructure (MR-Pd) for in_vivo, in situ catalytic Suzuki-Miyaura cross-coupling of iodoprazole and boronic ester to the anti-cancer agent, PP121 and its concomitant efficacy in 2D and 3D encapsulated structures containing PC3 cancer cells . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.